200 related articles for article (PubMed ID: 15942122)
1. Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients.
Mabuchi H; Higashikata T; Kawashiri M; Katsuda S; Mizuno M; Nohara A; Inazu A; Koizumi J; Kobayashi J
J Atheroscler Thromb; 2005; 12(2):111-9. PubMed ID: 15942122
[TBL] [Abstract][Full Text] [Related]
2. Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA.
Passi S; Stancato A; Aleo E; Dmitrieva A; Littarru GP
Biofactors; 2003; 18(1-4):113-24. PubMed ID: 14695926
[TBL] [Abstract][Full Text] [Related]
3. Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study.
Mabuchi H; Nohara A; Kobayashi J; Kawashiri MA; Katsuda S; Inazu A; Koizumi J;
Atherosclerosis; 2007 Dec; 195(2):e182-9. PubMed ID: 17681347
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia.
Malhotra HS; Goa KL
Drugs; 2001; 61(12):1835-81. PubMed ID: 11693468
[TBL] [Abstract][Full Text] [Related]
5. Effect of atorvastatin withdrawal on circulating coenzyme Q10 concentration in patients with hypercholesterolemia.
Chu CS; Kou HS; Lee CJ; Lee KT; Chen SH; Voon WC; Sheu SH; Lai WT
Biofactors; 2006; 28(3-4):177-84. PubMed ID: 17473378
[TBL] [Abstract][Full Text] [Related]
6. Assessment of atorvastatin effectiveness on serum PSA level in hypercholesterolemic males.
Khosropanah I; Falahatkar S; Farhat B; Heidari Bateni Z; Enshaei A; Allahkhah AA; Khosropanah D
Acta Med Iran; 2011; 49(12):789-94. PubMed ID: 22174166
[TBL] [Abstract][Full Text] [Related]
7. Effects of atorvastatin and atorvastatin withdrawal on soluble CD40L and adipocytokines in patients with hypercholesterolaemia.
Chu CS; Lee KT; Lee MY; Su HM; Voon WC; Sheu SH; Lai WT
Acta Cardiol; 2006 Jun; 61(3):263-9. PubMed ID: 16869445
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke.
Rundek T; Naini A; Sacco R; Coates K; DiMauro S
Arch Neurol; 2004 Jun; 61(6):889-92. PubMed ID: 15210526
[TBL] [Abstract][Full Text] [Related]
9. The effect of pravastatin and atorvastatin on coenzyme Q10.
Bleske BE; Willis RA; Anthony M; Casselberry N; Datwani M; Uhley VE; Secontine SG; Shea MJ
Am Heart J; 2001 Aug; 142(2):E2. PubMed ID: 11479481
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
[TBL] [Abstract][Full Text] [Related]
11. Effects of atorvastatin on coagulation parameters and homocysteine in patients with primary hypercholesterolemia.
Bolaman Z; Kadikoylu G; Ozgel N; Yenisey C
J Natl Med Assoc; 2006 Aug; 98(8):1273-7. PubMed ID: 16916124
[TBL] [Abstract][Full Text] [Related]
12. Serum from hypercholesterolemic patients treated with atorvastatin or simvastatin inhibits cultured human smooth muscle cell proliferation.
Arnaboldi L; Guzzetta M; Pazzucconi F; Radaelli G; Paoletti R; Sirtori CR; Corsini A
Pharmacol Res; 2007 Dec; 56(6):503-8. PubMed ID: 17959387
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
Baldassarre S; Scruel O; Deckelbaum RJ; Dupont IE; Ducobu J; Carpentier YA
Int J Cardiol; 2005 Oct; 104(3):338-45. PubMed ID: 16186066
[TBL] [Abstract][Full Text] [Related]
14. Interaction between a commercially available St. John's wort product (Movina) and atorvastatin in patients with hypercholesterolemia.
Andrén L; Andreasson A; Eggertsen R
Eur J Clin Pharmacol; 2007 Oct; 63(10):913-6. PubMed ID: 17701167
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepatic damage).
Han KH; Rha SW; Kang HJ; Bae JW; Choi BJ; Choi SY; Gwon HC; Bae JH; Hong BK; Choi DH; Han KR
J Clin Lipidol; 2012; 6(4):340-51. PubMed ID: 22836071
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias.
Yee HS; Fong NT
Ann Pharmacother; 1998 Oct; 32(10):1030-43. PubMed ID: 9793596
[TBL] [Abstract][Full Text] [Related]
17. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
18. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
19. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
[TBL] [Abstract][Full Text] [Related]
20. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.
Fonseca FA; Ruiz A; Cardona-Muñoz EG; Silva JM; Fuenmayor N; Marotti M;
Curr Med Res Opin; 2005 Aug; 21(8):1307-15. PubMed ID: 16083541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
